Latest filing published 23 Feb 2026 for Silexion Therapeutics Corp.
Filing timeline
BuySaleInsider track record
Ilan Hadar: trading record in brief
Ilan Hadar discloses dealings in 3 companies, chiefly Foamix Pharmaceuticals Ltd., Yarrow Bioscience, Inc. and Silexion Therapeutics Corp. Over a trading history stretching from 1 January 2018 to 20 February 2026, the count stands at 12 filings.
Sales make up the whole of the open-market record (2 sales, €139k). Besides market trades, the filings include 6 share grants and 2 option exercises.
The latest filing, published on 23 February 2026, reports a share grant in Silexion Therapeutics Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ilan Hadar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 64,350 shares0Ordinary SharesSEC:0001178913-26-000600:0
- 8,339 sharesCommon StockSEC:0001209191-20-018225:0
- 69,012 sharesCommon StockSEC:0001209191-20-018225:1
- 14,077 sharesOrdinary SharesSEC:0001209191-20-018195:0
- 116,501 sharesOrdinary SharesSEC:0001209191-20-018195:1
- 41,299 shares0Ordinary SharesSEC:0001209191-20-012196:0
- 9,420 shares@ US$3.5021.5% of flowOrdinary SharesSEC:0001209191-19-049203:0
- 34,392 shares@ US$3.5078.5% of flowOrdinary SharesSEC:0001209191-19-049203:1
- 40,712 shares0Ordinary SharesSEC:0001178913-19-000050:0
- 11,698 shares0Ordinary SharesSEC:0001178913-18-000728:0
- 5,032 shares0Ordinary SharesSEC:0001178913-18-000267:0
- 562 shares0Ordinary SharesSEC:0001178913-18-000267:1
12 of 12 declarations
